Purchase Order 75N92018P00121

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for a NextSeq 550 Sequencing System with HiSeq 500 trade-in, with a ceiling value of $224,400 and an award date of June 7, 2018. Work is performed at North Bethesda, Maryland. The purchase order is firm fixed price with an ultimate completion date of June 6, 2019. No set-aside category was applied.</p>

<p>The National Human Genome Research Institute issued a delivery order to Illumina, Inc. on July 30, 2019, with a ceiling value of $246,062.25 for genetic sequencing equipment and related genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD. The order was firm fixed price with no set-aside designation and an ultimate completion date of September 2, 2020.</p>

<p>The National Human Genome Research Institute issued a delivery order to Illumina, Inc. on September 1, 2017, with a ceiling value of $147,003.32 for genetic sequencing equipment and related genomic analysis technologies.</p> <p>Place of performance is North Bethesda, MD. The order is firm fixed price with an ultimate completion date of September 30, 2017. No set-aside was used.</p>

<p>The National Human Genome Research Institute issued a $15,321.60 delivery order to Illumina, Inc. on July 18, 2019, for genetic sequencing equipment and related genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD. The order has a firm fixed-price structure with an ultimate completion date of September 2, 2020. No set-aside was used for this award.</p>

<p>The National Human Genome Research Institute issued a delivery order to Illumina, Inc. on August 24, 2017, with a ceiling value of $149,817.44 for genetic sequencing equipment and related genomic analysis technologies.</p> <p>Place of performance is North Bethesda, MD. The order has a firm fixed-price structure and an ultimate completion date of January 25, 2018. No set-aside was used.</p>

<p>The National Human Genome Research Institute issued a delivery order to Illumina, Inc. on March 23, 2018, with a ceiling value of $38,699.62 for genetic sequencing equipment and related genomic analysis technologies.</p> <p>Place of performance is North Bethesda, MD. The order is firm fixed price and has an ultimate completion date of April 22, 2018. No set-aside was used.</p>

<p>The National Human Genome Research Institute issued a delivery order to Illumina, Inc. on September 10, 2015, with a ceiling value of $22,798.91 for genetic sequencing equipment and related genomic analysis technologies.</p> <p>Place of performance is North Bethesda, MD. The order is priced on a firm fixed-price basis with an ultimate completion date of October 9, 2015. No set-aside was used for this delivery order.</p>

<p>The National Human Genome Research Institute issued a delivery order to Illumina, Inc. on August 2, 2017, with a ceiling value of $143,999.36 for genetic sequencing equipment and related genomic analysis technologies.</p> <p>Place of performance is North Bethesda, MD. The order has a firm fixed-price structure with an ultimate completion date of September 1, 2017. No set-aside was used.</p>

<p>The National Human Genome Research Institute issued a delivery order to Illumina, Inc. on July 11, 2019, with a ceiling value of $29,082.24 for genetic sequencing equipment or consumables.</p> <p>Place of performance is Bethesda, MD 20892. The order has a firm fixed-price structure with an ultimate completion date of September 2, 2020. No set-aside was used.</p>

<p>The National Human Genome Research Institute issued a delivery order to Illumina, Inc. on August 21, 2018, with a ceiling value of $48,450.41 for genetic sequencing and genomic analysis equipment and supplies.</p> <p>Place of performance is Bethesda, MD 20892. The order is firm fixed-price and carries an ultimate completion date of September 2, 2020. No set-aside was used.</p>